Tumour-specific vector for gene therapy

US6936595B2 · kind B2 · utility

Assignee

• Heart Biosystems GMBH · DE

Inventors

• Jan-Heiner Kupper · Mauer, DE
• Ralph Meyer · Bad Windsheim, DE
• Mirella Meyer-Ficca · Kelheim, DE
• Reinhard Kandolf · Hechingen, DE

Key dates

• Filing date: Apr 2, 2002
• Grant date: Aug 30, 2005
• Expiry date: Apr 2, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2830/008
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a vector for the gene therapeutic treatment of tumours, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A.